Recent Company News

• 02:51 AM ET Aug 28, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:36 AM ET Sep 08, 2025
  

  Elekta appoints Klara Eiritz as new CFO, effective no later than March 2026 (SEK 44.30, 0.00)

• 02:31 AM ET Sep 03, 2025
  

  Elekta initiated sell at UBS (SEK 45.94, 0.00)

• 02:05 AM ET Aug 28, 2025
  

  StreetAccount Metrics Recap - Elekta Q1 Earnings (SEK 48.94, 0.00)

• 01:36 AM ET Aug 28, 2025
  

  Elekta reports Q1 Adj. EPS SEK0.31 vs consensus SEK0.28 (SEK 48.94, 0.00)

• 06:23 AM ET Aug 14, 2025
  

  StreetAccount Summary - European unusual volume traders

• 09:01 AM ET Jul 23, 2025
  

  Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy (SEK 48.74, +1.28)

• 07:34 AM ET Jul 04, 2025
  

  Elekta publishes Annual Report; includes it's sustainability information, based on GRI Standards as well as the EU Taxonomy regulation (SEK 49.28, -0.32)